Record of recommendation [electronic resource] : re: Degarelix (Firmagon®) in advanced or metastatic hormone dependent prostate cancer.

This version of the GALLOP Portal is in beta testing. 

We are still in the process of uploading all the documents and indexing them to support full-text searching. Some search results might be incomplete at this time.

Please contact cm@ola.org if you have any questions or comments.